Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Sidney Kimmel Cancer Center at Thomas Jefferson University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Intraoperative Celiac Plexus Neurolysis for Patients With Operable Pancreatic and Periampullary Cancer

Phase 3

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2008-12-11

Last Posted Date: 2025-05-15

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 438

Registration Number: NCT00806611

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Nausea and Vomiting In Patients Receiving Consecutive Days of Cisplatin

Terminated

Conditions: Metastatic Melanoma
Nausea

First Posted Date: 2008-07-16

Last Posted Date: 2025-05-06

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 8

Registration Number: NCT00716560

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Phase 1

Terminated

Conditions: Non-deletion 5q
Myelodysplastic Syndrome
Low to Intermediate-1 MDS
MDS

Interventions: Drug: Lenalidomide

First Posted Date: 2008-06-18

Last Posted Date: 2025-05-04

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 8

Registration Number: NCT00699842

Locations: 🇺🇸
Associates in Hematology-Oncology, PC, Chester, Pennsylvania, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

Phase 2

Completed

Conditions: Uveal Melanoma
Liver Metastases

Interventions: Drug: GM-CSF
Procedure: Embolization

First Posted Date: 2008-04-18

Last Posted Date: 2025-05-16

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 53

Registration Number: NCT00661622

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors

Phase 1

Completed

Conditions: Primary Brain Tumors
Brain Metastases

Interventions: Drug: Sorafenib
Drug: Temozolomide
Radiation: Radiotherapy

First Posted Date: 2008-03-20

Last Posted Date: 2025-05-02

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 35

Registration Number: NCT00639262

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Drug: Contrast Enhanced-Transrectal Ultrasound

First Posted Date: 2008-03-13

Last Posted Date: 2025-05-16

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 1

Registration Number: NCT00635167

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)

Phase 2

Terminated

Conditions: Non-Hodgkin Lymphoma

Interventions: Drug: Intravenous vitamin C

First Posted Date: 2008-02-29

Last Posted Date: 2025-05-16

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 2

Registration Number: NCT00626444

Locations: 🇺🇸
Jefferson-Myrna Brind Center of Integrative Medicine, Philadelphia, Pennsylvania, United States

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

Phase 3

Conditions: Colorectal Cancer

First Posted Date: 2008-02-15

Last Posted Date: 2013-12-18

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 900

Registration Number: NCT00617071

Locations: 🇺🇸
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Phase 1

Completed

Conditions: Cancer
Head and Neck Cancer
Pelvic Cancer
Nervous System Neoplasms
Thoracic Neoplasms

Interventions: Drug: Sunitinib
Radiation: External Beam Radiation Therapy

First Posted Date: 2007-02-21

Last Posted Date: 2025-05-02

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 39

Registration Number: NCT00437372

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation

Phase 2

Terminated

Conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

First Posted Date: 2007-01-31

Last Posted Date: 2016-10-21

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 21

Registration Number: NCT00429039

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy